SAMANTHA DAVIS: Open Payments
NPI 1235883620 · RICHMOND, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,296 in 66 payments from 14 companies in 2025. Trend: 2023 $1,000 · 2024 $2,335 · 2025 $1,296
Food & beverage: $1,296
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 18 | $465 |
| Takeda Pharmaceuticals U.S.A., Inc. | 17 | $186 |
| Ardelyx, Inc. | 9 | $154 |
| Janssen Biotech, Inc. | 7 | $140 |
| GENZYME CORPORATION | 3 | $91 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $62 |
| Aimmune Therapeutics, Inc. | 1 | $35 |
| QOL Medical, LLC | 2 | $35 |
| Madrigal Pharmaceuticals | 1 | $30 |
| Blueprint Medicines Corporation | 1 | $21 |
Products named: ENTYVIO, RINVOQ, IBSRELA, TREMFYA, SKYRIZI, DUPIXENT, LINZESS, CREON.
Industry payments across VA — which companies pay providers there.
